Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07025109 · ClinicalTrials.gov registry record · NA

Assessing Peer Support for Physical Activity in Women With HIV and Hypertension

A NA study of Hypertension and HIV, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07025109: Recruiting NA study of Hypertension and HIV, sponsored by University of Alabama at Birmingham.

NCT07025109 is a NA study of Hypertension and HIV that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07025109, a NA study of Hypertension and HIV, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical trial will assess the acceptability and feasibility of a peer-supported behavioral physical activity intervention for women living with HIV and Hypertension.

Primary Outcome

Measure of participants who withdraw from the behavioral trial in the intervention and the control groups to determine feasibility of enrolling and retaining individuals in the trial. Approximately 15% attrition is expected in a behavioral clinical trial. Higher levels of attrition relate to lower feasibility.

Conditions Studied

Interventions

  • BEHAVIORAL Peer support
  • BEHAVIORAL Exercise Prescription
  • BEHAVIORAL Blood pressure self monitoring

Study Locations (1)

Alabama

  • Department of Family & Community Medicine; University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-02-06
Est. Completion 2026-07-31
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT07025109 shows while recruiting

NCT07025109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Peer support is the first listed.

NCT07025109 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT07025109 about?

NCT07025109 is a clinical study titled "Assessing Peer Support for Physical Activity in Women With HIV and Hypertension". This clinical trial will assess the acceptability and feasibility of a peer-supported behavioral physical activity intervention for women living with HIV and Hypertension.

What is the current status of trial NCT07025109?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-02-06. Estimated completion is 2026-07-31.

What conditions does trial NCT07025109 study?

This clinical trial studies the following conditions: Hypertension, HIV.

What interventions are being tested in trial NCT07025109?

The interventions under investigation include: Peer support (BEHAVIORAL), Exercise Prescription (BEHAVIORAL), Blood pressure self monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT07025109?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07025109 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07025109's enrollment target sits among peer trials

50 367th of 470 higher than 96 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07025109, the US trial registry maintained by the National Library of Medicine. NCT07025109 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.